Medifast (NYSE:MED) Posts Quarterly Earnings Results, Beats Estimates By $0.26 EPS

Medifast (NYSE:MED) released its quarterly earnings results on Tuesday. The specialty retailer reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.26, Zacks reports. Medifast had a net margin of 1.09% and a return on equity of 15.98%. Medifast updated its Q1 2025 guidance to -0.500-0.000 EPS.

Medifast Stock Performance

Shares of Medifast stock opened at $16.05 on Wednesday. The company has a current ratio of 3.11, a quick ratio of 2.55 and a debt-to-equity ratio of 0.06. The company has a market cap of $175.59 million, a PE ratio of 24.32 and a beta of 1.14. The company has a 50 day moving average of $16.61 and a 200-day moving average of $18.05. Medifast has a 1-year low of $14.76 and a 1-year high of $49.90.

Analyst Ratings Changes

Separately, DA Davidson upgraded Medifast from an “underperform” rating to a “neutral” rating and raised their price target for the stock from $16.50 to $17.00 in a research report on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.